Abstract
Merkel cell carcinoma (MCC) is a rare aggressive skin tumor which shares histopathological and genetic features with small-cell lung carcinoma (SCLC), both are of neuroendocrine origin. Comparable to SCLC, MCC cell lines are classified into two different biochemical subgroups designated as ‘Classic’ and ‘Variant’. With the aim to identify typical gene-expression signatures associated with these phenotypically different MCC cell lines subgroups and to search for differentially expressed genes between MCC and SCLC, we used cDNA arrays to profile 10 MCC cell lines and four SCLC cell lines. Using significance analysis of microarrays, we defined a set of 76 differentially expressed genes that allowed unequivocal identification of Classic and Variant MCC subgroups. We assume that the differential expression levels of some of these genes reflect, analogous to SCLC, the different biological and clinical properties of Classic and Variant MCC phenotypes. Therefore, they may serve as useful prognostic markers and potential targets for the development of new therapeutic interventions specific for each subgroup. Moreover, our analysis identified 17 powerful classifier genes capable of discriminating MCC from SCLC. Real-time quantitative RT–PCR analysis of these genes on 26 additional MCC and SCLC samples confirmed their diagnostic classification potential, opening opportunities for new investigations into these aggressive cancers.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Baumann KI, Senok SS, Chan E and Yung WH . (2000). Merkel Cells, Merkel Cell Carcinoma and Neurobiology of the Skin, Suzuki H and Ono T (eds) Elsevier Science B.V.: Tokyo, pp 73–81.
Benzil DL, Finkelstein SD, Epstein MH and Finch PW . (1992). Cancer Res., 52, 2951–2956.
Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R, Gillette M, Loda M, Weber G, Mark EJ, Lander ES, Wong W, Johnson BE, Golub TR, Sugarbaker DJ and Meyerson M . (2001). Proc. Natl. Acad. Sci. USA, 98, 13790–13795.
Borges M, Linnoila RI, van de Velde HJ, Chen H, Nelkin BD, Mabry M, Baylin SB and Ball DW . (1997). Nature, 386, 852–855.
Botchkarev VA, Kief S, Paus R and Moll I . (1999). J. Invest. Dermatol., 113, 691–692.
Broers JL, Carney DN, de Ley L, Vooijs GP and Ramaekers FC . (1985). Proc. Natl. Acad. Sci. USA, 82, 4409–4413.
Broers JL, Carney DN, Klein Rot M, Schaart G, Lane EB, Vooijs GP and Ramaekers FC . (1986). J. Cell Sci., 83, 37–60.
Buchner K . (2000). J. Cancer Res. Clin. Oncol., 126, 1–11.
Carney DN, Gazdar AF, Bepler G, Guccion JG, Marangos PJ, Moody TW, Zweig MH and Minna JD . (1985). Cancer Res., 45, 2913–2923.
Carroll P, Lewin GR, Koltzenburg M, Toyka KV and Thoenen H . (1998). Nat. Neurosci., 1, 42–46.
Cook AL, Pollock PM, Welch J, Walsh MD, Bowman RV, Baumann KC, Hayward NK and Leonard JH . (2001). Int. J. Cancer, 93, 361–367.
Eisen MB, Spellman PT, Brown PO and Botstein D . (1998). Proc. Natl. Acad. Sci. USA, 95, 14863–14868.
Fong KM, Sekido Y and Minna JD . (1999). J. Thorac. Cardiovasc. Surg., 118, 1136–1152.
Garber ME, Troyanskaya OG, Schluens K, Petersen S, Thaesler Z, Pacyna-Gengelbach M, van de Rijn M, Rosen GD, Perou CM, Whyte RI, Altman RB, Brown PO, Botstein D and Petersen I . (2001). Proc. Natl. Acad. Sci. USA, 98, 13784–13789.
Gazdar AF, Carney DN, Nau MM and Minna JD . (1985). Cancer Res., 45, 2924–2930.
Goessling W, McKee PH and Mayer RJ . (2002). J. Clin. Oncol., 20, 588–598.
Halata Z, Grim M and Bauman KI . (2003). Anat. Rec., 271A, 225–239.
Iavarone A, Garg P, Lasorella A, Hsu J and Israel MA . (1994). Genes Dev., 8, 1270–1284.
Leonard JH and Bell JR . (1997). Australas. J. Dermatol., 38, 91–98.
Leonard JH, Bell JR and Kearsley JH . (1993). Int. J. Cancer, 55, 803–810.
Leonard JH, Cook AL, Nancarrow D, Hayward N, Van Gele M, Van Roy N and Speleman F . (2000). Cancer Detect. Prev., 24, 620–627.
Leonard JH, Cook AL, Van Gele M, Boyle GM, Inglis KJ, Speleman F and Sturm RA . (2002). Int. J. Cancer, 101, 103–110.
Leonard JH, Dash P, Holland P, Kearsley JH and Bell JR . (1995a). Int. J. Cancer, 60, 100–107.
Leonard JH and Hayard N . (1997). Genes Chromosomes Cancer, 20, 93–97.
Leonard JH, Ramsay JR, Kearsley JH and Birrell GW . (1995b). Int. J. Radiat. Oncol. Biol. Phys., 32, 1401–1407.
Levin NA, Brzoska PM, Warnock ML, Gray JW and Christman MF . (1995). Genes Chromosomes Cancer, 13, 175–185.
Metz KA, Jacob M, Schmidt U, Steuhl KP and Leder LD . (1998). Graefe's Arch. Clin. Exp. Ophthalmol., 236, 561–566.
Miller RW and Rabkin CS . (1999). Cancer Epidemiol. Biomarkers Prev., 8, 153–158.
Minna JD, Roth JA and Gazdar AF . (2002). Cancer Cell, 1, 49–52.
Moll I, Gillardon F, Waltering S, Schmelz M and Moll R . (1996). J. Cutan. Pathol., 23, 109–117.
Pattyn F, Speleman F, De Paepe A and Vandesompele J . (2003). Nucleic Acids Res., 31, 122–123.
Petersen I, Langreck H, Wolf G, Schwendel A, Psille R, Vogt P, Reichel MB, Ried T and Dietel M . (1997). Br. J. Cancer, 75, 79–86.
Pedersen N, Mortensen S, Sorensen SB, Pedersen MW, Rieneck K, Bovin LF and Poulsen HS . (2003). Cancer Res., 63, 1943–1953.
Popp S, Waltering S, Herbst C, Moll I and Boukamp P . (2002). Int. J. Cancer, 99, 352–360.
Ratner D, Nelson BR, Brown MD and Johnson TM . (1993). J. Am. Acad. Dermatol., 29, 143–156.
Ried T, Petersen I, Holtgreve-Grez H, Speicher MR, Schrock E, du Manoir S and Cremer T . (1994). Cancer Res., 54, 1801–1806.
Ronan SG, Green AD, Shilkaitis A, Huang TS and Das Gupta TK . (1993). J. Am. Acad. Dermatol., 29, 715–722.
Rosen ST, Gould VE, Salwen HR, Herst CV, Le Beau MM, Lee I, Bauer K, Marder RJ, Andersen R, Kies MS, Moll R, Franke WW and Radosevich JA . (1987). Lab. Invest., 56, 302–312.
Scaglione-Sewell B, Abraham C, Bissonnette M, Skarosi SF, Hart J, Davidson NO, Wali RK, Davis BH, Sitrin M and Brasitus TA . (1998). Cancer Res., 58, 1074–1081.
Schmidt U, Muller U, Metz KA and Leder LD . (1998). Am. J. Dermatopathol., 20, 346–351.
Tazaki M, Tazaki Y, Inoue T and Shimono M . (2000). Merkel Cells, Merkel Cell Carcinoma and Neurobiology of the Skin, Suzuki H and Ono T (eds) Elsevier Science B.V.: Tokyo, pp. 63–71.
Tusher VG, Tibshirani R and Chu G . (2001). Proc. Natl. Acad. Sci. USA, 98, 5116–5121.
Vandesompele J, De Paepe A and Speleman F . (2002a). Anal. Biochem., 303, 95–98.
Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A and Speleman F . (2002b). Genome Biol., 3, research0034.001–research0034.0011.
Van Gele M, Kaghad M, Leonard JH, Van Roy N, Naeyaert JM, Geerts ML, Van Belle S, Cocquyt V, Bridge J, Sciot R, De Wolf-Peeters C, De Paepe A, Caput D and Speleman F . (2000). Br. J. Cancer, 82, 823–826.
Van Gele M, Leonard JH, Van Limbergen H, Van Roy N, Van Belle S, Cocquyt V, De Paepe A, Salwen H and Speleman F . (2002). Int. J. Cancer, 101, 137–145.
Van Gele M, Speleman F, Vandesompele J, Van Roy N and Leonard JH . (1998). Cancer Res., 58, 1503–1508.
Zajchowski DA, Bartholdi MF, Gong Y, Webster L, Liu HL, Munishkin A, Beauheim C, Harvey S, Ethier SP and Johnson PH . (2001). Cancer Res., 61, 5168–5178.
Zhang L, Cilley RE and Chinoy MR . (2000). J. Surg. Res., 93, 108–119.
Acknowledgements
This work was supported by GOA Grant 12051397, FWO Grant G.0028.00 and the Queensland Cancer Fund and the Queensland Radium Institute Research Unit. Anthony L Cook is supported by a University of Queensland Mid Year Scholarship. Jo Vandesompele is sponsored by VEO-grant 011V1302. Nadine Van Roy is a postdoctoral researcher of the Fund for Scientific Research, Flanders. This paper presents the research results of the Belgian program of Interuniversity Poles of attraction initiated by the Belgian State, Prime Minister's Office, Science Policy Programming. The scientific responsibility is assumed by us. We would like to thank Drs MM Hughes, VM Hinkley, RW Allison, W Cockborn, TJ Harris and O Williams for their support in collecting the Queensland MCC specimens, from which the MCC cell lines were established, and H Salwen for providing MCC cell line MKL-2.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gele, M., Boyle, G., Cook, A. et al. Gene-expression profiling reveals distinct expression patterns for Classic versus Variant Merkel cell phenotypes and new classifier genes to distinguish Merkel cell from small-cell lung carcinoma. Oncogene 23, 2732–2742 (2004). https://doi.org/10.1038/sj.onc.1207421
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207421
Keywords
This article is cited by
-
Merkel cell carcinoma of the head and neck: emphasizing the risk of undertreatment
European Archives of Oto-Rhino-Laryngology (2016)
-
Assessment of Cancer Cell Line Representativeness Using Microarrays for Merkel Cell Carcinoma
Journal of Investigative Dermatology (2015)
-
Cytological and Immunocytochemical Features of Merkel Cell Carcinoma on Fine Needle Cytology Samples: A Study of 22 Cases
Endocrine Pathology (2015)
-
Distinct Gene Expression Profiles of Viral- and Nonviral-Associated Merkel Cell Carcinoma Revealed by Transcriptome Analysis
Journal of Investigative Dermatology (2013)
-
Merkel cell carcinoma in elderly: case report and review of the literature
Aging Clinical and Experimental Research (2013)